June 25, 2016
Recommended Topic Related To:


"For patients with chronic sinusitis and nasal polyps, reslizumab is particularly effective, according to a subgroup analysis of two pivotal phase 3 trials of the anti-interleukin-5 antibody.

These patients have an "unusual conste"...



Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Vira-A Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 3/28/2016

Vira-A (vidarabine monohydrate) Ophthalmic Ointment is an antiviral medication used to treat eye infections caused by the herpes virus. The brand name Vira-A is discontinued, but generic versions may be available. Common side effects of Vira-A (vidarabine monohydrate) include:

  • burning
  • stinging
  • pain
  • irritation
  • itching
  • redness
  • swelling
  • blurred vision
  • tearing
  • feeling like something is in the eye, or
  • sensitivity to light.

Administer approximately one-half inch of Vira-A Ophthalmic Ointment, 3%, into the lower conjunctival sac five times daily at three-hour intervals. Vira-A may interact with other eye medications. Tell your doctor all medications and supplements you use. It is unknown if Vira-A ophthalmic will harm a fetus. Tell your doctor if you are pregnant. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Vira-A (vidarabine monohydrate) Ophthalmic Ointment Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Vira-A FDA Prescribing Information: Side Effects
(Adverse Reactions)


Lacrimation, foreign body sensation, conjunctival injection, burning, irritation, superficial punctate keratitis, pain, photophobia, punctal occlusion, and sensitivity have been reported with VIRA-A (vidarabine) Ophthalmic Ointment, 3%. The following have also been reported but appear disease-related: uveitis, stromal edema, secondary glaucoma, trophic defects, corneal vascularization, and hyphema.

Read the entire FDA prescribing information for Vira-A (Vidarabine)

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.